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Atropisomeric biaryls, exemplified by 1,1′‐binapthyl‐2,2′‐diol (BINOL)[1](#anie201814381-bib-0001){ref-type="ref"} are valuable scaffolds for catalysis, materials, and medicine. BINOL itself is a building block for numerous catalyst scaffolds. *C* ~2~‐symmetric BINOLs are generally accessible through derivatization of enantiopure BINOL, which can be accessed by resolution[2](#anie201814381-bib-0002){ref-type="ref"} and also from commercial sources.[3](#anie201814381-bib-0003){ref-type="ref"} However, this strategy is not always feasible for non‐*C* ~2~‐symmetric derivatives.[4](#anie201814381-bib-0004){ref-type="ref"} One approach to this problem that may extend across a wide range of substrates is kinetic resolution (KR)---the achievement of resolution by virtue of unequal rates of reaction.[5](#anie201814381-bib-0005){ref-type="ref"}, [6](#anie201814381-bib-0006){ref-type="ref"} This is a valuable technique for obtaining extremely high levels of enantioenrichment in unreacted substrate through high selectivity factors (*s*) and control of conversion. Previous approaches to the KR[7](#anie201814381-bib-0007){ref-type="ref"} of BINOLs include Tsuji\'s palladium catalyzed alcoholysis of vinyl ether derivatives using a chiral diamine ligand, which enabled the recovery of enantioenriched unreacted substrate with *s* up to 36 (Figure [1](#anie201814381-fig-0001){ref-type="fig"} A).[8](#anie201814381-bib-0008){ref-type="ref"} An alternative approach from the Sibi group (Figure [1](#anie201814381-fig-0001){ref-type="fig"} B) involves employing a chiral 4‐dimethylaminopyridine equivalent to enable enantioselective *O*‐acylation of a mono‐functionalized BINOL derivative with *s* up to 38.[9](#anie201814381-bib-0009){ref-type="ref"} A related acylative approach from Zhao (Figure [1](#anie201814381-fig-0001){ref-type="fig"} C) employs an *N*‐heterocyclic carbene in the presence of an α‐alkoxyaldehyde. Through internal redox, this generates an *N*‐acyl azolium salt that leads to kinetic resolution of BINOLs with *s* up to \>100.[10](#anie201814381-bib-0010){ref-type="ref"} There are a number of enzymatic kinetic resolutions of BINOL that can deliver enantioenriched materials;[11](#anie201814381-bib-0011){ref-type="ref"} of particular note is the KR and dynamic KR from Akai that employs immobilized *Pseudomonas* sp. lipoprotein lipase (Toyobo LIP‐301), in the presence of isopropenyl acetate (Figure [1](#anie201814381-fig-0001){ref-type="fig"} D).[12](#anie201814381-bib-0012){ref-type="ref"}

![Previous approaches to catalytic KR of BINOLS, and our strategy.](ANIE-58-4596-g001){#anie201814381-fig-0001}

We reasoned that an enantioselective *O*‐functionalization, mediated by a chiral counterion[13](#anie201814381-bib-0013){ref-type="ref"} in the presence of an alkylating agent, could effect a simple and functional group tolerant KR of BINOLs. We have previously demonstrated that racemic 2‐tetralones can be *O*‐alkylated with high levels of atropselectivity.[14](#anie201814381-bib-0014){ref-type="ref"} Here we build on this approach but extend our strategy to the *O*‐functionalization of naptholates. This could enable access to non‐*C* ~2~‐symmetric BINOLs with the high levels of enantioenrichment required for the construction of catalysts, whilst also being a scalable and operationally simple procedure.

Our investigation started with the kinetic resolution of monomethyl BINOL **1** (Table [1](#anie201814381-tbl-0001){ref-type="table"}). *O*‐Alkylation of **1** with benzyl bromide in the presence of *N*‐benzyl quinidinium chloride **3** and potassium phosphate gave poor conversion (13 %) and *s* of 3.1 (entry 1). This could be significantly augmented through the selection of catalysts bearing electron withdrawing groups on the *N*‐benzyl moiety: catalyst **4** gave better conversion and a much‐improved selectivity (*s*=13, entry 2). The use of benzyl iodide as the electrophile gave a broadly similar selectivity (*s*=12, entry 3), but higher conversion (53 %) was achieved when using benzene as the solvent (entry 4). This is a valuable observation, as temporal control of conversion is important for attaining high levels of enantioselectivity in kinetic resolutions. We explored this further with a change of electrophile to benzyl tosylate;[15](#anie201814381-bib-0015){ref-type="ref"} this gave lower selectivity (*s*=8.5, entry 5) but enabled greater control of conversion. Consequently, we reasoned that through optimization of catalyst structure we would be able to build upon and modify this set of reaction conditions to attain sufficiently high selectivity in the kinetic resolution.

###### 

Optimization: kinetic resolution of BINOLs.^\[a\]^ ![](ANIE-58-4596-g004.jpg "image")

  Entry                                Cat.   Base^\[b\]^   Solvent             Bn‐X    *s* ^\[c\]^
  ------------------------------------ ------ ------------- ------------------- ------- -------------
  1                                    3      K~3~PO~4~     PhMe                BnBr    3.1
  2                                    4      K~3~PO~4~     PhMe                BnBr    13
  3                                    4      K~3~PO~4~     PhMe                BnI     12
  4                                    4      K~3~PO~4~     PhH                 BnI     14
  5                                    4      K~2~CO~3~     PhH                 BnOTs   8.5
  6                                    5      K~2~CO~3~     PhH                 BnOTs   21
  7                                    6      K~2~CO~3~     PhH                 BnOTs   21
  8                                    7      K~2~CO~3~     PhH                 BnOTs   21
  9                                    8      K~2~CO~3~     PhH                 BnOTs   33^\[d\]^
  10                                   8      K~2~CO~3~     PhH:Et~2~O^\[e\]^   BnOTs   35^\[d\]^
  ![](ANIE-58-4596-g005.jpg "image")                                                    

\[a\] Conditions: substrate **1** (0.02 mmol), cat. (0.1 equiv), base (5.0 equiv), solvent (\[substrate\]=0.1 [m]{.smallcaps}), 298 K, 48 h. \[b\] base: 50 % aq., w/w. \[c\] *s* determined from enantiomeric ratio (e.r.) values of unreacted starting material and *O*‐alkylated product; e.r. values were determined by chiral stationary phase HPLC. \[d\] \[substrate\]=0.025 M. \[e\] 9:1 PhH:Et~2~O, v/v.
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We were able to increase selectivity through the application of catalyst **5**, which bears a trisubstituted arene on the pendant *N*‐substituent (*s*=21, entry 6).[16](#anie201814381-bib-0016){ref-type="ref"} We next examined the effect of small changes around this catalyst structure. Catalyst **6** bears a 2‐methyl group on the quinoline and was designed to test if quinoline *N*‐functionalization was affecting performance; this gave identical selectivity (*s*=21, entry 7). We also examined whether the quinidine backbone was more effective than the cinchonine backbone through evaluation of catalyst **7**; this ultimately gave identical selectivity (*s*=21, entry 8) though a shorter reaction time to reach viable conversion was deemed advantageous. Examination of catalyst **8**, which bears a 3‐ethyl group gave significantly better performance when operated at a lower concentration (*s*=33, entry 9) which was further augmented (to *s*=35, entry 10) through the application of diethyl ether as a co‐solvent; furthermore, this reduced reaction time to 24 h.

With a working process in hand, we examined the scope of our counterion‐mediated kinetic resolution across both *C* ~2~‐ and non *C* ~2~‐symmetric substrates (Table [2](#anie201814381-tbl-0002){ref-type="table"}). Monomethyl BINOL can be alkylated with *s*=35, enabling recovery of unreacted substrate **1** in 47 % yield (98:2 e.r.); ^\[17\]^ the absolute configuration of the major enantiomer of **1** is (*R*)‐, through comparison with literature values and by preparation of an authentic sample from (*R*)‐BINOL.[18](#anie201814381-bib-0018){ref-type="ref"} Removal of the *O*‐alkyl groups in **1** or its *O*‐benzylated analogue is easily achieved.[14](#anie201814381-bib-0014){ref-type="ref"} The alkyl group can be varied to encompass both *O*‐isopropyl **9** and benzyl ethers **10**. 6′‐Nitro‐BINOL derivative **11** can be recovered from the alkylation reaction in 39 % yield and \>99:1 e.r. (*s*=46). Alkyl substituents such as methyl are also tolerated in the 6′ position as in **12**. Non‐symmetric 7‐substituted systems are broadly well tolerated with both controllable conversion and high selectivity. Thus substrates **13**--**17** are all effective in the KR with good selectivity factors, enabling isolation of substrate in usefully high levels of enantioenrichment. Substitution in the 6‐position is possible without deleterious effects on the reaction: **18**--**21** are all successfully *O*‐alkylated with good selectivity. Variation in the substituent at the 5‐position is also well tolerated: **22**--**24** can be isolated with high levels of selectivity. Phenanthrene biaryl **25** is also selectively alkylated (*s*=30). There is relatively little sensitivity to changes in substituents in the 4‐position: **26**--**29** are all viable substrates that proceed to afford recovered substrate in good yields and enantioselectivities. *C* ~2~‐symmetric substrates are also tolerated under this protocol. 7,7′‐dibromo derivative **30** functions well under the optimized reaction conditions (*s*=33). However, these positions appear to be somewhat sensitive to substitution: **31** and **32** are both less selective substrates than most others. In contrast, 6,6′‐dibromo BINOL substrate **33** (*s*=34) is a significantly better substrate for the reaction, as is the 6,6′‐diphenyl substrate **34** (*s*=39). Changing the aryl group as in **35**--**37** is also well tolerated with little effect on selectivity 5,5′‐substituted BINOLS are also good substrates for the kinetic resolution: **38** and **39** are successful and selective substrates but 5,5′‐diphenyl substrate **40** is significantly less selective. We are also able to resolve substrates bearing substitution in the 4,4′ positions, but this appears to be relatively sensitive to the size of the substituent: 4,4′‐dibromo **41** (*s*=21) is relatively selective, but 4,4′‐diphenyl substrate **42** (*s*=16) is significantly less successful. In contrast, a smaller substituent (4,4′‐dimethyl substrate **43**) enables isolation of unreacted starting substrate in good selectivity (*s*=34).

###### 

Scope of counterion‐mediated kinetic resolution of C~2~‐ and non‐C~2~‐symmetric BINOLs.

  ------------------------------------
  ![](ANIE-58-4596-g006.jpg "image")
  ------------------------------------

Reaction conditions: BINOL (0.15 mmol), cat. **8** (0.1 equiv), K~2~CO~3~ (5.0 equiv, sat. aq.), BnOTs (1.5 equiv), 9:1 PhH:Et~2~O (v/v, \[BINOL\]=0.025 [m]{.smallcaps}); reaction time 20--48 h, 298 K.[19](#anie201814381-bib-0019){ref-type="ref"} Conversions and *s*electivity factors were determined from e.r. values of unreacted starting material and *O*‐alkylated product[20](#anie201814381-bib-0020){ref-type="ref"} (see Supporting Information for full details). e.r. and yield are given first for unreacted starting material; figures in parentheses that follow are for *O*‐benzylated product. Enantiomeric ratios were determined by chiral stationary phase HPLC. Yields are for isolated and purified material. Positions around the BINOL core are indicated in red numerals.
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The scalability and practicability of this process is demonstrated by a 22 mmol scale reaction (Scheme [1](#anie201814381-fig-5001){ref-type="fig"}).

![Reaction conditions: BINOL **33** (22 mmol), cat. **8** (0.1 equiv), K~2~CO~3~ (5.0 equiv, sat. aq.), BnOTs (1.5 equiv), 9:1 PhH:Et~2~O (v/v, \[BINOL\]=0.025 [m]{.smallcaps}); reaction time 36 h, 298 K. Enantiomeric ratios were determined by chiral stationary phase HPLC. Yields are for isolated and purified material.](ANIE-58-4596-g003){#anie201814381-fig-5001}

Treatment of *rac*‐BINOL derivative **33** (10.1 g) with catalyst **8** (synthesized in 2 steps from commercial material) and benzyl tosylate enabled isolation of enantioenriched unreacted BINOL **33** in 43 % yield and 99:1 e.r. (*s*=40 at 54 % conversion). This result demonstrates that the KR process can be applied on a practical multi‐gram scale for those interested in the synthesis of highly enantioenriched BINOLs.

From a mechanistic perspective, we propose that rapid and reversible deprotonation of **1** affords diastereoisomeric BINOLate ammonium salts **45** and **46**, and that these react at different rates in the alkylation step in the presence of benzyl tosylate (Figure [2](#anie201814381-fig-0002){ref-type="fig"}).

![Proposed mechanism of observed kinetic resolution.](ANIE-58-4596-g002){#anie201814381-fig-0002}

A proposed transition structure **47** involves hydrogen bonding from the α‐C−H of the ammonium salt and the secondary alcohol to the BINOLate anion, with an additional C−H⋅⋅⋅O hydrogen bond from the benzylic electrophile C−H to the methyl ether. This is consistent with a recently proposed model from Fan and Hong and reflects the observed absolute configuration of the *O*‐benzylated product and unreacted substrate.[21](#anie201814381-bib-0021){ref-type="ref"}

In conclusion, we have demonstrated that a readily available chiral ammonium salt can discriminate between the enantiomeric forms of a wide range of BINOLs in an alkylative KR process. This is a selective, viable and practical process for the synthesis of useful quantities of both *C* ~2~ and non‐*C* ~2~‐symmetric BINOLs at the high levels of enantioselectivity required for catalysis and related applications.
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